APLN and cardiac hypertrophy: Similarly, lower apelin levels were demonstrated inpatients with T2D and hypertension, and negatively correlated with cardiac hypertrophy,a known complication of hypertension [45 ].Together, these results highlight the increased risk of hypertension and subsequentcardiovascular complications correlating with lower apelin levels.